Fig. 1

Tile panel demonstrating clinical, radiological and molecular characteristics of patients with histone H3 K27-mutant diffuse non-midline glioma (n = 16) and H3 G34-mutant diffuse hemispheric glioma (n = 9) in the Kansai Network